HR 5343

Ensuring Patient Access to Critical Breakthrough Products Act

Bill status

Status
Reported
Sponsor
Rep. Blake D. Moore [R-UT-1]
Cosponsors
56
Policy area
Health
Introduced
2025-09-15
Latest action
2025-09-17: Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3.

Committee referrals

Recent actions

  • 2025-09-17: Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3.
  • 2025-09-17: Committee Consideration and Mark-up Session Held
  • 2025-09-15: Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • 2025-09-15: Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • 2025-09-15: Introduced in House